MétaCan
Menu
Back to cohort
Record W2558713658 · doi:10.1093/ofid/ofw194.48

Donor Efficacy in Fecal Microbiota Transplantation for Recurrent Clostridium difficile: Evidence From a 1,999-Patient Cohort

2016· article· en· W2558713658 on OpenAlex

Why this work is in the frame

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

affAt least one author lists a Canadian institution in the pinned OpenAlex snapshot.

Bibliographic record

VenueOpen Forum Infectious Diseases · 2016
Typearticle
Languageen
FieldMedicine
TopicClostridium difficile and Clostridium perfringens research
Canadian institutionsOttawa Hospital
Fundersnot available
KeywordsClostridium difficileMedicineFecal bacteriotherapyFecesC difficileCohortInternal medicineTransplantationCohort studyMicrobiologyAntibioticsBiology

Abstract

fetched live from OpenAlex

Background. Recurrent Clostridium difficile infection (CDI) is a public health challenge and fecal microbiota transplantation (FMT) has emerged as an effective therapeutic option. Although FMT is used for treating recurrent CDI, there is no robust evidence evaluating if different donors have an impact on the clinical cure rate. We aim to evaluate if there are differences in FMT efficacy for CDI between donors from a public stool bank. Methods. Donors were selected using a 178-point clinical assessment and 30 laboratory investigations for infectious and microbiome-mediated diseases where only 2.8% of candidate donors qualify. Among selected donors, fecal microbiota preparations (FMPs) were produced according to standard FMP manufacturing practices. Donor-specific units were tracked by a quality assurance (QA) system that linked to de-identified individual patient outcomes. QA data was consecutively collected from 482 healthcare facilities across 50 states and 7 countries between January 16, 2014 and April 12, 2016. Donors were included if their material was used in over 10 reported patients over the study period. The primary outcome was physician reported clinical cure as per standard of care follow-up. Descriptive statistics and chi-square analysis was conducted. Results. Overall, 28 donors (Figure 1) were used in 1,999 patients. Overall, the clinical cure rate from physician-reported data across all 28 donors was 84.4% with a range of 69.2–95.2% (Figure 2). One outlier donor was found to have a statistically significant lower clinical cure rate (70.9%, p = 0.05). However, upon sensitivity analysis, the lower efficacy was driven by one site (overall clinical cure for all donors at site of 50.7%, p < 0.05) and the reduced clinical cure rate was not seen across other hospitals that the donor's material was used. Otherwise, there was no statistically significant differences between donor FMT material and clinical cure for CDI not responsive to standard therapy. Figure 1: Donor characteristics Figure 2: Clinical efficacy reported by donor Conclusion. To our knowledge, this is the largest study assessing clinical efficacy for FMT in CDI by donor and suggests it is unlikely that different donors have an impact on efficacy. Disclosures. M. Osman, OpenBiome: Employee, Salary; Z. Stoltzner, OpenBiome: Employee, Salary; K. O'Brien, OpenBiome: Employee, Salary; K. Ling, OpenBiome: Employee, Salary; E. Koelsch, OpenBiome: Employee, Salary; N. Dubois, OpenBiome: Employee, Salary; M. Smith, OpenBiome: Employee, Salary. Finch Therapeutic: Board Member, Employee and Shareholder, Equity and Salary; Z. Kassam, OpenBiome: Employee, Salary. Finch Therapeutic: Consultant and Shareholder, Equity and Research support

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.001
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.218
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.001
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.026
GPT teacher head0.320
Teacher spread0.295 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it